Stimulation Therapy for Apnea: Reporting Thoughts (START)

University of Pittsburgh

Status: Completed

Conditions: Obstructive Sleep Apnea

Treatments: Device: Upper airway stimulation (Inspire Medical Systems, Inc.)

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04768543

STUDY20090150

Details and patient eligibility

About

Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy. Although adherence to UAS is higher than to PAP, there remain patients who are not using UAS consistently. The aim of this project is to explore critical factors in the use of UAS by OSA patients using qualitative research methods (personal interviews). The proposed study will provide crucial information about patients' concerns regarding UAS use and suggestions for how to support new UAS recipients.

Enrollment: 26 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age and older
• ADHERE registry patient
• Received UAS implant from June 2017 to present

Exclusion criteria

• Patients without up to date contact information

Trial design

26 participants in 1 patient group

Exposure

Description:

Patients with moderate to severe OSA treated with UAS (Inspire Medical Systems, Inc)

Treatment:

Device: Upper airway stimulation (Inspire Medical Systems, Inc.)